Cero Therapeutics Holdings Inc. Insider Trading
CERO
No open-market buying or selling by insiders.
No executive or director has bought shares on the open market in the last two years.
Get an email when CERO's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Dec 11, 2024 – Dec 13, 2024 | YK Bioventures Opportunities GP I, LLC Large holder | SoldNo plan 3 parts | 5,957,250 | $0.07 average | 400K | 31% | Form 4 |
| Dec 6, 2024 – Dec 10, 2024 | Mitchell William Kossar Large holder | SoldNo plan 3 parts | 3,658,364 | $0.10 average | 383K | 16% | Form 4 |
- Dec 11, 2024 – Dec 13, 2024No planYK Bioventures Opportunities GP I, LLCLarge holder · sold 5,957,250 at avg $0.07400K31% of stake
- Dec 6, 2024 – Dec 10, 2024No planMitchell William KossarLarge holder · sold 3,658,364 at avg $0.10383K16% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biological Products, (No Diagnostic Substances) · Pick stocks to compare with CERO
Spot a number that looks wrong? Check it in CERO's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing CERO
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.